Our Approach
We Address a Market Gap
At Cube Labs, we understand well the challenges associated with growing a startup, particularly in the highly regulated life sciences space. It is with this understanding in mind that we provide our portfolio companies with comprehensive entrepreneurial and operational support.
Our core team has extensive experience in startup development, with members who manage all the commercial aspects of our portfolio companies, including:
Cube Labs'
4 Steps
Assessment
Our team conducts a thorough analysis and validation of research projects or proposals, evaluating business models, intellectual property (IP) and the patentability of the projects. We assess the Scientific Team's expertise to ensure alignment with investment and development plan objectives. Legal, regulatory, clinical and market aspects are also reviewed for comprehensive evaluation.
Incubation
This phase lasts approximately 1-2 months, in which we establish new academic spin-offs and qualify portfolio companies as innovative startups with a clear development plan and roadmap.
Acceleration
In this phase, we provide our portfolio companies with comprehensive strategic, entrepreneurial, financial and operational support to accelerate market access.
Growth & Exit
Capitalizing on Created Value:
Market Entry: We focus on commercializing or licensing technologies internationally to scale up market presence.
Exit Strategy: Options include pursuing an Initial Public Offering (IPO), engaging in mergers and acquisitions (M&A), or selling to industrial partners to optimize value creation.